跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Enrylaze - SFDA Drug Approval Details
Approvals
/
SFDA
/
Enrylaze
Authorized
BIOLOGICAL
Enrylaze
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
46f269e6b9ce6bf3
Company
Unknown
Type
Biological
Approval Details
Approval Id
46f269e6b9ce6bf3
Drug Approval Sfda Name
Enrylaze
Trade Name
Enrylaze
Generic Name
RECOMBINANT CRISANTASPASE
Register Number
1911246279
Register Year
2024
Drug Type
Biological
Route Of Administration
Intramuscular and intravenous use
Package Type
Vial
Package Size
3
Size
0.5
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store in a refrigerator (2°c – 8°c)
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000002760-10-100000074038
Price
11250.3
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
46f269e6b9ce6bf3
Type
Biological
Back to SFDA Approvals